STAA SEC Filings: 8-K, 10-Q, S-3 & 424B – STAAR Surgical

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 13, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

8-K

STAAR Surgical Reports Third Quarter 2026 Results with Net Sales of $83.4 Million

Nov 4, 2026

8-K/A

Former CEO David Bailey Returns as Chief Commercial Officer to Accelerate EVO ICL Growth and Expand Global Refractive Surgery Markets

Oct 5, 2026

8-K

STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer

Sep 9, 2026

8-K

STAAR Surgical Company Reports Financial Results for Quarter Ended July 3, 2026

Aug 12, 2026

8-K

STAAR Surgical Appoints Warren Foust as CEO and Deborah Andrews as EVP and CFO

Aug 6, 2026

8-K

STAAR Surgical Company Announces Results of 2026 Annual Meeting of Shareholders

Jun 22, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B2

1,739,000 Shares

Aug 9, 2018

424B5

1,739,000 Shares

Aug 7, 2018

424B5

300,000 Shares of Common Stock

Jun 17, 2009

424B5

4,255,319 Shares of Common Stock

Jun 17, 2009

424B3

7,690,849 Shares of Common Stock

Apr 25, 2008

424B5

3,130,435 Shares of Common Stock

Apr 26, 2007

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 24, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 21, 2024

S-3/A

Common StockPreferred StockWarrantsDebt Securities______________- EFFECTIVE

Feb 19, 2021

S-3/A

Common StockPreferred StockWarrantsDebt Securities______________ EFFECTIVE

Aug 6, 2020

S-8

2,650,000(2)

Aug 4, 2020

S-3

Common StockPreferred StockWarrantsDebt Securities______________ EFFECTIVE

May 6, 2020

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 4, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 4, 2026

DFAN14A

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material

Dec 19, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Dec 19, 2025

DFAN14A

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material

Dec 17, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Dec 17, 2025

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

BlackRock, Inc. (Filed by)

Oct 27, 2026

ANDREWS DEBORAH J (Reporting)

Aug 18, 2026

Foust Warren (Reporting)

Aug 18, 2026

Michna Magda (Reporting)

Aug 18, 2026

SCHEDULE 13G/A

Madison Avenue Partners, LP (Filed by)

Aug 14, 2026

Foust Warren (Reporting)

Aug 4, 2026

Other

TYPE

HEADLINE

FILED AT

STAAR Surgical Company STAA · SEC Filings